Results 121 to 130 of about 5,153,703 (360)
ABSTRACT Aim The National Clinical Database (NCD) of Japan is the largest nationwide registry, covering over 95% of surgeries in the country. This 2022 annual report summarizes the short‐term outcomes of gastroenterological surgeries and discusses trends and insights over the past decade.
Koshi Kumagai +19 more
wiley +1 more source
Factors associated with distant metastasis in pediatric thyroid cancer: evaluation of the SEER database [PDF]
Zeming Liu +12 more
openalex +1 more source
Dual‐Scale Transformer Fusion With Meta Learning for Micro Metastasis Detection in Thyroid Cancer
A dual‐scale transformer model enhanced by meta‐learning enables accurate detection of tiny metastatic lesions in thyroid cancer. By combining cellular and tissue‐level features, the method outperforms existing models and shows strong adaptability to rare cases with limited data.
Jingtao Wang +5 more
wiley +1 more source
Tracheal collapse as acute presentation in metastatic thyroid cancer [PDF]
Marco Maglione +3 more
openalex +1 more source
ABSTRACT Background Since 1997 the Building Trades National Medical Screening Program (BTMed) has offered medical exams to construction workers employed in US nuclear weapons facilities. The process consists of two steps: (1) a detailed work history interview; and (2) a medical exam.
Knut Ringen +11 more
wiley +1 more source
A Population‐Based Assessment of Cancer Risk in Children With VACTERL
ABSTRACT Cancer risk in children with VACTERL, a nonrandom co‐occurrence of ≥ 3 defects (vertebral, anal, cardiac, tracheoesophogeal fistula, renal, and limb), remains unclear. We evaluated this association in a population‐based study. We analyzed data from the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Study, a US registry linkage ...
Ji Yun Tark +15 more
wiley +1 more source
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai +29 more
wiley +1 more source

